Etoposide%20phosphate
Showing 1 - 25 of 1,776
Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant Trial in New York (Etoposide; Oral, 50 Mg, Focused
Recruiting
- Diffuse Intrinsic Pontine Glioma
- Diffuse Midline Glioma, H3 K27M-Mutant
- Etoposide; Oral, 50 Mg
- Focused ultrasound with neuro-navigator-controlled sonication
-
New York, New YorkColumbia University Irving Medical Center
Feb 28, 2023
DLBCL (DLBCL) Trial (Glofitamab, Obinutuzumab, Tocilizumab)
Recruiting
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Glofitamab
- +6 more
-
Pembroke Pines, Florida
- +3 more
Jan 23, 2023
B-cell Non Hodgkin Lymphoma Trial (Odronextamab, Loncastuximab tesirine, Rituximab)
Not yet recruiting
- B-cell Non Hodgkin Lymphoma
- Odronextamab
- +8 more
- (no location specified)
Aug 7, 2023
Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma, Mixed Glioma Trial in Minneapolis, Portland (Carboplatin, Etoposide,
Completed
- Anaplastic Oligoastrocytoma
- +3 more
- Carboplatin
- +7 more
-
Minneapolis, Minnesota
- +1 more
Mar 11, 2022
Non-Hodgkin's Lymphoma Trial in Philadelphia (drug, procedure, genetic)
Completed
- Non-Hodgkin's Lymphoma
- Bendamustine
- +6 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Sep 14, 2022
Lymphoma Trial in Houston (Radiation Therapy, Dexamethasone, Etoposide phosphate)
Recruiting
- Lymphoma
- Radiation Therapy
- +5 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 9, 2022
T-cell Non-Hodgkin Lymphoma Trial in Boston (Cyclophosphamide, Doxorubicin, Vincristine)
Terminated
- T-cell Non-Hodgkin Lymphoma
- Cyclophosphamide
- +12 more
-
Boston, Massachusetts
- +1 more
Jan 26, 2023
Adult Acute Lymphocytic Leukemia Trial in Frankfurt (Cyclophosphamide, Dexamethasone, Vincristine)
Completed
- Adult Acute Lymphocytic Leukemia
- Cyclophosphamide
- +20 more
-
Frankfurt, GermanyUniversity of Frankfurt, Medical Dept. II
Aug 17, 2022
Hemophagocytic Lymphohistiocytosis Trial in United States (Ruxolitinib, Dexamethasone, Etoposide)
Recruiting
- Hemophagocytic Lymphohistiocytosis
- Ruxolitinib
- +2 more
-
Phoenix, Arizona
- +9 more
Jan 9, 2023
Glioma, Pilocytic Astrocytoma, Anaplastic Astrocytoma Trial in Saint Louis (MRI-guided laser ablation, Doxorubicin, Etoposide)
Recruiting
- Glioma
- +8 more
- MRI-guided laser ablation
- +4 more
-
Saint Louis, MissouriWashington University School of Medicine
Jun 22, 2022
Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood Trial in United States (AC220, Cytarabine,
Completed
- Lymphoblastic Leukemia, Acute, Childhood
- Myelogenous Leukemia, Acute, Childhood
- AC220
- +3 more
-
Los Angeles, California
- +10 more
Mar 24, 2022
Malignant Rhabdoid Tumor, Atypical Teratoid Rhabdoid Tumor Trial in United States (drug, procedure, radiation)
Recruiting
- Malignant Rhabdoid Tumor
- Atypical Teratoid Rhabdoid Tumor
- alisertib
- +9 more
-
Los Angeles, California
- +10 more
Aug 1, 2022
Treatment Refusal Trial in Guangzhou (Gemcitabine, etoposide, Pegaspargase)
Unknown status
- Treatment Refusal
- Gemcitabine
- +3 more
-
Guangzhou, Please Select, ChinaSun Yat-sen University Cancer Center
Dec 16, 2020
Acute Myeloid Leukemia Trial in Memphis (Venetoclax, Azacitidine, Cytarabine)
Not yet recruiting
- Acute Myeloid Leukemia
- Venetoclax
- +9 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jul 21, 2023
Hemophagocytic Syndrome, T/NK-Cell Lymphoma Trial in Zhengzhou (Ruxolitinib, Etoposide, Dexamethasone, Gemcitabine,
Recruiting
- Hemophagocytic Syndrome
- T/NK-Cell Lymphoma
- Ruxolitinib, Etoposide, Dexamethasone, Gemcitabine, Pegaspargase, cis-platinum
-
Zhengzhou, Henan, ChinaOncology Department of The First Affiliated Hospital of Zhengzho
Aug 3, 2021
Acute Lymphoblastic Leukemia, Acute Lymphoblastic Lymphoma Trial in Australia, United States (Prednisone, Vincristine,
Recruiting
- Acute Lymphoblastic Leukemia
- Acute Lymphoblastic Lymphoma
- Prednisone
- +21 more
-
Palo Alto, California
- +6 more
May 2, 2022
Recurrent Adult Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia Trial in
Recruiting
- Recurrent Adult Acute Myeloid Leukemia
- +2 more
- Sirolimus
- +3 more
-
Philadelphia, PennsylvaniaThomas Jefferson University
Dec 7, 2020
Acute Myeloid Leukemia Trial in Houston (Crenolanib besylate, Idarubicin, Cytarabine)
Completed
- Acute Myeloid Leukemia
- Crenolanib besylate
- +7 more
-
Houston, TexasMD Anderson Cancer Center
Jul 17, 2020
Metastatic NUT Carcinoma, Unresectable NUT Carcinoma Trial (Cisplatin, Etoposide, Etoposide Phosphate)
Withdrawn
- Metastatic NUT Carcinoma
- Unresectable NUT Carcinoma
- Cisplatin
- +4 more
- (no location specified)
Sep 25, 2020
Small Cell Lung Cancer Trial in Worldwide (Pembrolizumab, MK-4830, MK-5890)
Recruiting
- Small Cell Lung Cancer
- Pembrolizumab
- +6 more
-
Gilbert, Arizona
- +48 more
Jan 19, 2023
Anaplastic Ependymoma, Atypical Teratoid/Rhabdoid Tumor, CNS Germ Cell Tumor Trial in Houston (drug, procedure, biological)
Recruiting
- Anaplastic Ependymoma
- +14 more
- Etoposide
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Aug 17, 2022
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Buffalo (biological, drug, radiation)
Completed
- Chronic Myeloproliferative Disorders
- +7 more
- anti-thymocyte globulin
- +8 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jul 19, 2021
Childhood Favorable Prognosis Hodgkin Lymphoma, Childhood Lymphocyte Depletion Hodgkin Lymphoma, Childhood Mixed Cellularity
Completed
- Childhood Favorable Prognosis Hodgkin Lymphoma
- +5 more
- radiation therapy
- +11 more
-
Arcadia, CaliforniaChildren's Oncology Group
Mar 26, 2021
Classic Hodgkin Lymphoma Trial (procedure, biological, drug, other, radiation)
Not yet recruiting
- Classic Hodgkin Lymphoma
- Biospecimen Collection
- +19 more
- (no location specified)
Jan 6, 2023